A Phase Ib Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Teriparatide (Primary)
- Indications Hypoparathyroidism; Osteoporosis
- Focus Pharmacokinetics
- Sponsors Entera Bio
- 09 Jan 2018 Status changed from recruiting to completed.
- 07 Feb 2017 Planned End Date changed from 1 Aug 2016 to 1 Aug 2017.
- 07 Feb 2017 Planned primary completion date changed from 1 Aug 2016 to 1 Aug 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History